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The central position of cardiovascular disease in both the 
biology and the economics of medicine is clear-it accounts 
for an extraordinary proportion of short- and long-term 
morbidity and represents a major proportion of the health 
care expenditures by western nations. Over the past decade, 
both the technologies available to treat cardiovascular dis- 
ease and the delivery of those technologies have expanded 
rapidly. With the resources consumed by health care con- 
tinuing to grow at an uncomfortable pace, society has begun 
the difficult task of reining in that growth. 
under the real world umbrella of uncertainty will become 
increasingly relevant as the medical profession is forced to 
confront difficult and uncomfortable choices. Indeed, the 
careful application of formal explicit systems of decision 
making may allow clinicians to maintain a greater degree of 
control over their destiny and their patients’ health than 
would otherwise be possible. 
Clinical Trials Are Not Enough 
Formal Approaches to Medical 
Decision Making 
With cardiovascular care holding such a prominent posi- 
tion, it will bear substantial portions of the burden of 
restraint. Under such circumstances, it is essential that the 
clinicians who currently control the treatment of cardiovas- 
cular disease reflect on how such restraints will and should 
affect the care they deliver. Both the American College of 
Cardiology and the American College of Physicians have 
recognized the need for a measured and rational approach to 
ensuring that high quality cardiovascular care be provided at 
reasonable cost. Each has commissioned standing commit- 
tees to review current and future patterns of practice in a 
rational, measured, consistent manner-the Cardiovascular 
Norms Committee in the case of the American College of 
Cardiology and the Clinical Efficacy Assessment Subcom- 
mittee in the case of the American College of Physicians. 
The Society for Medical Decision Making, now beginning 
its 9th year, was organized to foster the application of 
rational formal approaches to both the study and the practice 
of medical decision making. Our membership includes poli- 
cymakers, psychologists, decision scientists and medical 
informaticians as well as clinicians. Techniques developed 
by our members to analyze and rationalize decisions made 
The 1987 Regenstrief Conference on the role of decision 
modeling in providing quality and cost-conscious care for 
patients with cardiovascular disease has provided an ex- 
traordinary opportunity for discussion and collaboration 
among three communities of investigators and clinicians. 
Although some overlap has existed among the membership 
of the American College of Physicians, the American Col- 
lege of Cardiology and the Society for Medical Decision 
Making, the preparation of the reports for the conference 
and the 3 days at McCormick’s Creek have fostered the 
evolution of a joint agenda and identified matches between 
problems and analytic solutions. Such collaborations will 
focus on the central dilemmas of cardiovascular care, but 
their effective solution awaits the evolution of improved and 
more easily understood models and the collection of proper 
data for and their application to those models. Notwithstand- 
ing the exalted position of the randomized clinical trial in 
academia, it is no longer reasonable to plan a trial to answer 
every important question. Trials are expensive, often nar- 
rowly focused and provide data with a short half-life of 
relevance when the underlying medical technologies are in 
evolution. In such circumstances, we must turn to a combi- 
nation of trials, clinical data bases, administrative (for ex- 
ample, billing and insurance) data bases and normative 
modeling, each liberally sprinkled with sensitivity analyses, 
to address key questions in a timely manner. 
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New Role for Physicians in Medical 
Decision Making 
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In the past, research on the quality and rationality of 
medical care has been hindered by limited interest and 
funding and by resistance among the clinical community. 
01989 by the American College of Cardiology 0735-1097/89/$3.50 
JACC Vol. 14, No. 3 PAUKER 73A 
September 1989:72A-3A ROLE OF THE SOCIETY FOR MEDICAL DECISION MAKING 
The current economic climate should leave little doubt about 
the relevance of formal approaches to medical decision 
making to the profession, to our patients and to those 
concerned with financing medical care. With the explosion 
of information necessary for medical practice, with elec- 
tronic data bases replacing memorization and with physician 
extenders supplementing our physical skills, it becomes 
increasingly clear that the process of medical decision mak- 
ing may well be the central function of the profession, one 
toward which we must direct research and improve practice. 
A portion of the formal analysis of clinical practice can be 
viewed as professional introspection. During that process, 
we sometimes recognize prevalent medical practices that are 
inadequately justified; those insights can be uncomfortable. 
That discomfort is often enhanced by the complexity of 
decision models and the clinician’s lack of familiarity with 
formal quantitative techniques. In the 1990s. the necessity 
for justifying routine practices (particularly those that con- 
sume, or appear to consume, substantial resources) should 
bring both interest and resources to our modeling communi- 
ties. One might even imagine the emergence of “dueling 
models.” a face-off between analysts who argue for and 
against a specific technology or patient management strat- 
egy. Each model might develop a constituency, perhaps 
based on its approach or underlying assumptions, but more 
likely based on its conclusions. 
Limitations of Decision Modeling 
From the perspective of the community of decision 
modelers, a note of caution and restraint must be interjected. 
Any formal model of clinical choice must be interpreted 
cautiously. Models cannot replace experienced judgment 
and rarely reflect the real world in its full splendor or 
complexity. There are always simplifications and, as pointed 
out by several reports in this Symposium, these can intro- 
duce substantial biases and errors. To the extent that every 
model is merely a reflection of the real world, all models 
have “bugs” or inadequacies. The question is never whether 
a model is correct in some absolute sense, but rather 
whether it is “good enough”-good enough to provide some 
insights into the clinical problem, good enough to enhance 
the clinician’s judgment, good enough to help maintain the 
quality while perhaps reducing the cost of medical care. 
Even the ideal model cannot replace clinical judgment. It 
merely contributes an additional perspective from which 
high quality patient care can be delivered. 
